School of Medicine


Showing 1-20 of 62 Results

  • Rosa Bacchetta

    Rosa Bacchetta

    Professor (Research) of Pediatrics (Stem Cell Transplantation)

    Current Research and Scholarly InterestsIn the coming years, I plan to further determine the genetic and immunological basis of diseases with autoimmunity or immune dysregulation in children. I believe that much can still be learned from the in depth mechanistic studies of pediatric autoimmune diseases. Genomic analysis of the patients' samples has become possible which may provide a rapid indication of altered target molecules. I plan to implement robust functional studies to define the consequences of these genetic abnormalities and bridge them to the patient's clinical phenotype.

    Understanding functional consequences of gene mutations in single case/family first and then validating the molecular and cellular defects in other patients with similar phenotypes, will anticipate and complement cellular and gene therapy strategies.

    For further information please visit the Bacchetta Lab website:
    http://med.stanford.edu/bacchettalab.html

  • Laura K. Bachrach

    Laura K. Bachrach

    Professor of Pediatrics (Endocrinology) at the Lucile Salter Packard Children's Hospital, Emerita

    Current Research and Scholarly InterestsPrevention of osteoporosis begins in childhood and adolescence by measures that maximize acquistion of bone mineral during the critical adolescent years. Body mass, calcium nutriture, physical activity, growth and sex steroid hormones, and genetic factors are all thought to be important determinants of bone mass although the relative contribution of each remains controversial.

  • Justin Nathaniel Baker

    Justin Nathaniel Baker

    Deborah E. Addicott - John A. Kriewall and Elizabeth A. Haehl Family Professor of Pediatrics

    BioAs a Pediatric Oncologist, Palliative Care Physician, and Phase I and End– of– Life Care Clinical Investigator, I am intimately aware of the distress experienced by children with advanced cancer and the ethical and end– of– life/bereavement issues surrounding their disease progression. I currently serve as the Chief of the Division of Quality of Life and Pediatric Palliative Care here at Stanford, as well as the Director of the Quality of Life for All (QoLA) Program. Additionally, I serve as the Associate Chief Quality Officer for Patient Experience and Holistic Care. In my past career at St Jude, I served as the Director of our large Pediatric Hematology/Oncology Fellowship Program for more than a decade. My research interests include ethical considerations surrounding enrollment in Phase I clinical trials, AYA palliative oncology care, end– of– life decision making, grief and bereavement, integrating palliative care into the ongoing care of children with cancer as well as patient– reported outcomes and pain and symptom control in the context of pediatric oncology care. I have received significant extramural funding for my research, and I have participated in dozens of studies related to pediatric palliative care. I have authored ~250 academic works on palliative care subjects within the context of pediatric oncology. In sum, I am a recognized global expert and leader in the field of Pediatric Palliative Care.

  • Karthik Balakrishnan, MD, MPH, FAAP, FACS

    Karthik Balakrishnan, MD, MPH, FAAP, FACS

    Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics

    Current Research and Scholarly InterestsDr. Balakrishnan's research focuses on innovative ways to improve and standardize treatments and measure outcomes in complex pediatric airway and aerodigestive conditions , as well as ways to reduce treatment costs and medical errors. By improving outcomes and reducing costs, he aims to improve the value of care, while also optimizing patient and caregiver experience during the care process.

  • Malathi Balasundaram

    Malathi Balasundaram

    Clinical Associate Professor, Pediatrics - Neonatal and Developmental Medicine

    Current Research and Scholarly InterestsFamily-centered Care in the NICU

  • Imelda Balboni

    Imelda Balboni

    Clinical Associate Professor, Pediatrics - Rheumatology

    Current Research and Scholarly InterestsPediatric systemic lupus erythematosus;
    Autoimmune disease;
    Proteomics and autoantigen microarray technology

  • Yair Bannett

    Yair Bannett

    Instructor, Pediatrics

    Current Research and Scholarly InterestsDr. Bannett seeks to use data-driven methods to develop reliable quality measures for management of children with developmental and behavioral (DB) conditions in community-based primary care. Current observational studies use multi-level analysis of electronic health record data and clinician interviews. Dr. Bannett plans to use natural language processing to accurately assess quality of care, with the ultimate goal of improving health care delivery for children with DB conditions.

  • Donald Barr

    Donald Barr

    Professor (Teaching) of Pediatrics (General Pediatrics), Emeritus

    BioDonald Barr is a Professor of Pediatrics in the Stanford School of Medicine, and Professor by Courtesy in the Graduate School of Education. He teaches in the Undergraduate Program in Human Biology, where he helped to found Human Biology's curriculum in health policy. His research has studied the effect of the organizational structure of the U.S. medical care delivery system on the quality of primary care. He has also studied cultural and linguistic barriers to health care access for low-income patients, and factors associated with higher rates of attrition from pre-medical studies among minority students at Stanford and other universities. The fourth edition of his book, Introduction to U.S. Health Policy: The Organization, Financing, and Delivery of Health Care in America, was published in 2016. The third edition of his book, Health Disparities in the United States: Social Class, Race, Ethnicity and the Social Determinants of Health, was published in 2019. In June 2003 Dr. Barr was awarded the Lloyd W. Dinkelspiel Award for Distinctive Contribution to Undergraduate Education at Stanford University. In 2006 he received the Miriam Aaron Roland Prize, which recognizes Stanford faculty who engage and involve students in integrating academic scholarship with significant and meaningful volunteer service to society.

  • Dorsey Bass

    Dorsey Bass

    Associate Professor of Pediatrics (Gastroenterology), Emeritus

    Current Research and Scholarly InterestsOur laboratory is interested in the pathophysiology, immunology, and epidemiology of viral gastroenteritis.

  • Hannah Bassett

    Hannah Bassett

    Clinical Associate Professor, Pediatrics

    Current Research and Scholarly InterestsUnderstanding how to implement real time patient-centered healthcare cost transparency in the acute care setting and how this transparency effects patient and system-level outcomes.

    Understanding how to best decrease unnecessary variation in clinical care through implementation of clinical effectiveness tools.

  • Glaivy Batsuli, MD

    Glaivy Batsuli, MD

    Assistant Professor of Pediatrics (Hematology/Oncology)

    Current Research and Scholarly InterestsHemophilia is a rare inherited X-linked bleeding disorder characterized by the deficiency of blood clotting proteins factor VIII or factor IX. These individuals are at risk for spontaneous bleeds and trauma or surgery-induced bleeding. There have been remarkable advancements in the management of hemophilia to prevent these bleeding episodes and improve quality of life. However, the presence of neutralizing antibodies, called inhibitors, still dictates access to novel therapies such as factor replacement for bleed management and now FDA-approved gene therapies. The Batsuli Lab is focused on elucidating mechanisms of the immune response to blood coagulation proteins in bleeding disorders in order to develop strategies and therapeutics for inhibitor prevention and tolerance induction.

    Dr. Batsuli's clinical research interests also include clinical trial participation for novel therapeutics & interventions in bleeding disorders such as hemophilia and von Willebrand disease in addition to coagulation issues & outcomes in ultra-rare bleeding disorders and sickle cell disease.